Zepteon Overview

  • Founded
  • 2012
Founded
  • Status
  • Private
  • Employees
  • 2
Employees
  • Latest Deal Type
  • Angel
  • Latest Deal Amount
  • $210K
Latest Deal Amount

Zepteon General Information

Description

Developer of chromatography resins. The company develops chromatography resins which are capable of separating antibodies with specific sugar structures (nonfucosylated) that are more potent against diseases like cancer.

Contact Information

Website
www.zepteon.com
Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Other Devices and Supplies
Other Industries
Biotechnology
Primary Office
  • 42 Chauncy Street
  • Suite 10A
  • Boston, MA 02111
  • United States
+1 (617) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Zepteon Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Angel (individual) 09-Apr-2015 $210K 00000 Completed Startup
To view Zepteon’s complete valuation and funding history, request access »

Zepteon Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of chromatography resins. The company develops chromatography resins which are capable of separating antibodie
Other Devices and Supplies
Boston, MA
2 As of 2015
00000
0000000000 00000

00000000

velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident,
0000000000000
Paris, France
000 As of 0000
00000
00000000 00000

00000000

ate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proiden
0000000000000
Beit-Haemek, Israel
000 As of 0000
0000
00.00 0000-00-00
000000&0 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Zepteon Competitors (3)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Cellectis Formerly VC-backed Paris, France 000 00000 00000000 00000
0000000000 0000000 Formerly PE-Backed Beit-Haemek, Israel 000 0000 000000&0 0000
000000000 00000000 Formerly VC-backed Billerica, MA 00 00000 000000&0 00000
You’re viewing 3 of 3 competitors. Get the full list »

Zepteon Patents

Zepteon Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20190194248-A1 Polypeptide separation methods Pending 20-Jul-2011 00000000
US-20130084648-A1 Polypeptide separation methods Granted 20-Jul-2011 00000000 0
CA-2842559-A1 Polypeptide separation methods Abandoned 20-Jul-2011 00000000
JP-2014527518-A Polypeptide separation method Pending 20-Jul-2011 00000000
US-10221210-B2 Polypeptide separation methods Active 20-Jul-2011 C07K1/22
To view Zepteon’s complete patent history, request access »

Zepteon Executive Team (2)

Name Title Board Seat Contact Info
Austin Boesch Co-Founder, Board Member & Chief Executive Officer
Glen Bolton Ph.D Co-Founder, Board Member & Chief Operating Officer
To view Zepteon’s complete executive team members history, request access »

Zepteon Board Members (2)

Name Representing Role Since
Austin Boesch Zepteon Co-Founder, Board Member & Chief Executive Officer 000 0000
Glen Bolton Ph.D Zepteon Co-Founder, Board Member & Chief Operating Officer 000 0000
To view Zepteon’s complete board members history, request access »

Zepteon Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial